Literature DB >> 19869100

SEROLOGICAL RELATIONSHIPS OF TYPE-SPECIFIC AND DEGRADED PNEUMOCOCCI.

H A Reimann1.   

Abstract

1. Immune sera prepared with the degraded or variant forms of pneumococci (R strains) are similar in their reactions to sera prepared with the protein or cell solutions of pneumococci. They contain antibodies reactive with the protein of all types of pneumococci, but no antibodies reactive with the type-specific substances. 2. Pneumococci of the variant or R form, regardless of type derivation, are serologically identical and have the antigenic characteristics of pneumococcus protein. They evoke the species-specific and not the type-specific antibodies. 3. Antipneumococcus sera obtained by immunization with S strains may contain species-specific antibodies in addition to those which are type-specific. Each kind of antibody can be removed separately from these sera by selective absorption with the R or S strains of pneumococci.

Year:  1926        PMID: 19869100      PMCID: PMC2131091          DOI: 10.1084/jem.43.1.107

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  IMMUNOLOGICAL RELATIONSHIPS OF CELL CONSTITUENTS OF PNEUMOCOCCUS.

Authors:  O T Avery; M Heidelberger
Journal:  J Exp Med       Date:  1923-06-30       Impact factor: 14.307

2.  IMMUNOLOGICAL RELATIONSHIPS OF CELL CONSTITUENTS OF PNEUMOCOCCUS : SECOND PAPER.

Authors:  O T Avery; M Heidelberger
Journal:  J Exp Med       Date:  1925-08-31       Impact factor: 14.307

3.  VARIATIONS IN SPECIFICITY AND VIRULENCE OF PNEUMOCOCCI DURING GROWTH IN VITRO.

Authors:  H A Reimann
Journal:  J Exp Med       Date:  1925-04-30       Impact factor: 14.307

4.  IMMUNOLOGICAL REACTIONS OF THE ISOLATED CARBOHYDRATE AND PROTEIN OF PNEUMOCOCCUS.

Authors:  O T Avery; H J Morgan
Journal:  J Exp Med       Date:  1925-08-31       Impact factor: 14.307

5.  THE PRODUCTION OF ANTIPNEUMOCOCCIC SERUM.

Authors:  R Cole; H F Moore
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

  5 in total
  10 in total

1.  IN VITRO TRANSFORMATION OF PNEUMOCOCCAL TYPES : I. A TECHNIQUE FOR INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES IN VITRO.

Authors:  M H Dawson; R H Sia
Journal:  J Exp Med       Date:  1931-10-31       Impact factor: 14.307

2.  THE INTERCONVERTIBILITY OF "R" AND "S" FORMS OF PNEUMOCOCCUS.

Authors:  M H Dawson
Journal:  J Exp Med       Date:  1928-03-31       Impact factor: 14.307

3.  THE OCCURRENCE OF DEGRADED PNEUMOCOCCI IN VIVO.

Authors:  H A Reimann
Journal:  J Exp Med       Date:  1927-04-30       Impact factor: 14.307

4.  STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : I. ANTIBODY RESPONSE OF RABBITS IMMUNIZED WITH TYPE III PNEUMOCOCCUS.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1927-03-31       Impact factor: 14.307

5.  THE OCCURRENCE OF ROUGH PNEUMOCOCCI IN VIVO.

Authors:  J R Paul
Journal:  J Exp Med       Date:  1927-10-31       Impact factor: 14.307

6.  IMMUNOLOGICAL PROPERTIES OF A TYPICAL (S-PRODUCING) AND A DEGRADED (NON-S-PRODUCING) STRAIN OF TYPE II PNEUMOCOCCUS WITH SPECIAL REFERENCE TO PROTECTIVE ANTIBODIES.

Authors:  E L Gaspari; W L Fleming; J M Neill
Journal:  J Exp Med       Date:  1927-06-30       Impact factor: 14.307

7.  STUDIES CONCERNING THE RELATIONSHIP BETWEEN PNEUMOCOCCI AND STREPTOCOCCI.

Authors:  H A Reimann
Journal:  J Exp Med       Date:  1927-01-01       Impact factor: 14.307

8.  REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : I. THE ANTIBODY RESPONSE.

Authors:  L A Julianelle
Journal:  J Exp Med       Date:  1930-02-28       Impact factor: 14.307

9.  A TYPE SPECIFIC SUBSTANCE DISTINCT FROM THE SPECIFIC CARBOHYDRATE IN PNEUMOCOCCUS TYPE I.

Authors:  J F Enders
Journal:  J Exp Med       Date:  1930-07-31       Impact factor: 14.307

10.  STUDIES ON PATHOGENIC B. COLI FROM BOVINE SOURCES : II. MUTATIONS AND THEIR IMMUNOLOGICAL SIGNIFICANCE.

Authors:  T Smith; G Bryant
Journal:  J Exp Med       Date:  1927-06-30       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.